Medical Bulletin of the Ministry of Internal Affairs Medical Bulletin of the Ministry of Internal Affairs Медицинский вестник МВД 2073-8080 92409 10.52341/20738080_2024_133_6_33 Эндокринология Endocrinology Эндокринология CARDIORENAL ANEMIC SYNDROME AND DIABETES MELLITUS КАРДИОРЕНАЛЬНЫЙ АНЕМИЧЕСКИЙ СИНДРОМ И САХАРНЫЙ ДИАБЕТ ЧЕРНАВСКИЙ С. В. ChERNAVSKIY S. V. chernavskijsv@mail.ru

доктор медицинских наук;

doctor of medical sciences;

 Рукавицын Олег Анатольевич Rukavicyn Oleg Anatol'evich ngc@list.ru

доктор медицинских наук;

doctor of medical sciences;

 СМИРНОВА М. А. SMIRNOVA M. A. smirnovama@bk.ru

кандидат медицинских наук;

candidate of medical sciences;

 КОРОЛЕВА Е. С. KOROLEVA E. S. lizakostyuchenko00@mail.ru ФГБУ «Главный военный клинический госпиталь имени академика Н.Н. Бурденко» Россия Federal State Budgetary Institution "Main Military Clinical Hospital named after Academician N.N. Burdenko" Russian Federation ФГБОУ ВО «Российский биотехнологический университет (Росбиотех)» Россия Federal State Budgetary Educational Institution of Higher Education “Russian Biotechnology University (Rosbiotech)” Russian Federation ФБГОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Россия Federal State Budgetary Educational Institution of Additional Professional Education "Russian Medical Academy of Continuous Professional Education" Russian Federation ФГБУ "Главный военный клинический госпиталь им.академика Н.Н.Бурденко" Минобороны России Москва Россия Main Military Hospital named after N.Burdenko under The Ministry of Defence of The Russian Federation Moscow Russian Federation ФБГОУ ДПО «Российская медицинская академия непрерывного про- фессионального образования» Россия Federal State Budgetary Educational Institution of Additional Professional Education "Russian Medical Academy of Continuous Professional Education" Russian Federation ФГБУ «Главный военный клинический госпиталь имени академика Н.Н. Бурденко» Россия Federal State Budgetary Institution "Main Military Clinical Hospital named after Academician N.N. Burdenko" Russian Federation 24 12 2024 24 12 2024 2024 6 33 41 22 12 2024 https://vestnikmvd.editorum.ru/en/nauka/article/92409/view

Исследования последних лет показали существование прочной взаимозависимости между хронической сердечной недостаточностью, почечной недостаточностью и анемией. Заболевания сердца и почек имеют общие традиционные факторы риска, включая сахарный диабет. Нарушения углеводного обмена существенно влияют на развитие компонентов кардиоренально-анемического синдрома. В свою очередь, анемический синдром у больных сахарным диабетом рассматривается как многофакторный процесс, оказывающий выраженное отрицательное влияние на течение хронической болезни почек и сердечнососудистых заболеваний, ухудшая их течение и прогноз.

Recent researches have revealed strong interdependence between congestive heart failure, renal failure and anemia. Heart and kidney diseases have the same traditional risk factors including diabetes mellitus. Disorders of carbohydrate metabolism have a significant effect on the development of cardiorenal anemic syndrome components. On the other hand, the anemic syndrome in patients with diabetes mellitus is considered as a multifactorial process with a pronounced negative effect on the progression of chronic kidney disease and coronary vascular diseases worsening their course and prognosis

 кардиоренальный анеми- ческий синдром сахарный диабет анемия осложнения хроническая сердечная не- достаточность хроническая болезнь почек cardiorenal anemic syndrome diabetes mellitus anemia complications congestive heart failure chronic kidney disease

World Heart Report 2023: Confronting the World’s Number One Killer. Geneva, Switzerland. World Heart Federation. – 2023. World Heart Report 2023: Confronting the World’s Number One Killer. Geneva, Switzerland. World Heart Federation. – 2023. The cardio renal anemia syndrome: correcting anemia in patients with resistant congestive heart failure can improve both cardiac and renal functional and reduce hospitalizations / D. Silverberg, D.Wexler, M. Blum, A. Iaina // Clinical nephrology. – 2003. – Vol. 60. – Suppl. – 1. – P. 93–102. The cardio renal anemia syndrome: correcting anemia in patients with resistant congestive heart failure can improve both cardiac and renal functional and reduce hospitalizations / D. Silverberg, D.Wexler, M. Blum, A. Iaina // Clinical nephrology. – 2003. – Vol. 60. – Suppl. – 1. – P. 93–102. Kazmi W., Kausz A., Khan S. et al. Anemia: an early complication of chronic renal insufficiency. Am. J. Kidney Dis. – 2001; 38: 803–812. Kazmi W., Kausz A., Khan S. et al. Anemia: an early complication of chronic renal insufficiency. Am. J. Kidney Dis. – 2001; 38: 803–812. Романенко Н.А., Бессмельцев С.С., Розанова О.Е., Карпова, Н.С., Абдулкадыров К.М. Влияние уровня ФНО-α на эффективность коррекции анемии у больных лимфопролиферативными заболеваниями // Онкогематология. – 2010;(3):22–28. Romanenko N.A., Bessmel'cev S.S., Rozanova O.E., Karpova, N.S., Abdulkadyrov K.M. Vliyanie urovnya FNO-α na effektivnost' korrekcii anemii u bol'nyh limfoproliferativnymi zabolevaniyami // Onkogematologiya. – 2010;(3):22–28. Levin A. Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin / A. Levin, C.R. Thompson, J. Ethier [et al.] // Am. J. Kidney. Dis. – 1999. – Vol. 34. – Р. 125–134. Levin A. Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin / A. Levin, C.R. Thompson, J. Ethier [et al.] // Am. J. Kidney. Dis. – 1999. – Vol. 34. – R. 125–134. Vaziri N.D. Erytropoetin and transferrin metabolism in nephrotic syndrome // Am. J. Kidney Dis. – 2001; 38: 1–8. Vaziri N.D. Erytropoetin and transferrin metabolism in nephrotic syndrome // Am. J. Kidney Dis. – 2001; 38: 1–8. McClellan W., Flanders W.D., Langston R.D. et al. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-basedstudy // J. Am. Soc. Nephrol. – 2002; 13: 1928–1936. McClellan W., Flanders W.D., Langston R.D. et al. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-basedstudy // J. Am. Soc. Nephrol. – 2002; 13: 1928–1936. Anker S.D., Sharma R. The syndrome of cardiac cachexia // Int. J. Cardiol. – 2002; 85: 51–66. Anker S.D., Sharma R. The syndrome of cardiac cachexia // Int. J. Cardiol. – 2002; 85: 51–66. Anand I., McMurray J.J.V., Whitmore J. et al. Anemia and its relationship to clinical outcome in heart failure // Circulation. – 2004; 110: 149-154. Anand I., McMurray J.J.V., Whitmore J. et al. Anemia and its relationship to clinical outcome in heart failure // Circulation. – 2004; 110: 149-154. Ткаченко Е.И., Боровкова Н.Ю., Буянова М.В. Анемия при хронической сердечной недостаточности: взгляд на патогенез и пути коррекции // Доктор.Ру. – 2019. – № 2 (157) . – С. 31–36. Tkachenko E.I., Borovkova N.Yu., Buyanova M.V. Anemiya pri hronicheskoy serdechnoy nedostatochnosti: vzglyad na patogenez i puti korrekcii // Doktor.Ru. – 2019. – № 2 (157) . – S. 31–36. Abramov D., Cohen R.S., Katz S.D., Mancini D., Maurer M.S. Comparison of blood volume characteristics in anemic patients with low versus preserved left ventricular ejection fraction // Am J Cardiol. – 2008; 102: 1069–1072. Abramov D., Cohen R.S., Katz S.D., Mancini D., Maurer M.S. Comparison of blood volume characteristics in anemic patients with low versus preserved left ventricular ejection fraction // Am J Cardiol. – 2008; 102: 1069–1072. Андреичев Л.А., Балеева Л.В. Анемия хронических заболеваний // Рус. мед. журн. – 2014; 2: 50–5. Andreichev L.A., Baleeva L.V. Anemiya hronicheskih zabolevaniy // Rus. med. zhurn. – 2014; 2: 50–5. Symeonidis A., Kouraklis-Symeonidis A., Psiroyiannis A., et al. Inappropriately low erythropoietin response for the degree of anemia in patients with noninsulin – dependent diabetes mellitus // Ann. Hematol. – 2006. – Vol. 85. – № 2. – P. 79–85. Symeonidis A., Kouraklis-Symeonidis A., Psiroyiannis A., et al. Inappropriately low erythropoietin response for the degree of anemia in patients with noninsulin – dependent diabetes mellitus // Ann. Hematol. – 2006. – Vol. 85. – № 2. – P. 79–85. Шестакова М.В., Мартынов С.А., Ильин А.В. и др. Анемия при диабетической нефропатии: распространенность, клинические и патофизиологические аспекты // Терапевтический архив. – 2008. – № 6. – С. 41–47. Shestakova M.V., Martynov S.A., Il'in A.V. i dr. Anemiya pri diabeticheskoy nefropatii: rasprostranennost', klinicheskie i patofiziologicheskie aspekty // Terapevticheskiy arhiv. – 2008. – № 6. – S. 41–47. Thomas M.C. Epidemiology of hemoglobin levels in patients with type 2 diabetes / M.C. Thomas, C. Tsalamandris, R.J. MacIsaac, G. Jerums // American Journal of Kidney Diseases. – 2006. – Vol. 48. – P. 537–545. Thomas M.C. Epidemiology of hemoglobin levels in patients with type 2 diabetes / M.C. Thomas, C. Tsalamandris, R.J. MacIsaac, G. Jerums // American Journal of Kidney Diseases. – 2006. – Vol. 48. – P. 537–545. Mrozikiewicz-Rakowska B., Chylińska A., Sieńko D. Vitamin B 12 in diabetes – a new treatment paradigm? // Clin. Diabetol. – 2020. – Vol. 9. – № 6. – P. 489–496. Mrozikiewicz-Rakowska B., Chylińska A., Sieńko D. Vitamin B 12 in diabetes – a new treatment paradigm? // Clin. Diabetol. – 2020. – Vol. 9. – № 6. – P. 489–496. Bareford D., Jennings P.E., Stone P.C., Baar S., Barnett A.H., Stuart J. Effects of hyperglycaemia and sorbitol accumulation on erythrocyte deformability in diabetes mellitus // J Clin Pathol. – 1986 Jul; 39(7):722–7. Bareford D., Jennings P.E., Stone P.C., Baar S., Barnett A.H., Stuart J. Effects of hyperglycaemia and sorbitol accumulation on erythrocyte deformability in diabetes mellitus // J Clin Pathol. – 1986 Jul; 39(7):722–7. Donnelly L.A., Dennis J.M., Coleman R.L., Sattar N., Hattersley A.T., Holman R.R., Pearson E.R. Risk of Anemia With Metformin Use in Type 2 Diabetes: A MASTERMIND Study // Diabetes Care. – 2020 Oct; 43(10):2493–2499. Donnelly L.A., Dennis J.M., Coleman R.L., Sattar N., Hattersley A.T., Holman R.R., Pearson E.R. Risk of Anemia With Metformin Use in Type 2 Diabetes: A MASTERMIND Study // Diabetes Care. – 2020 Oct; 43(10):2493–2499. Kaiser A.B., Zhang N., Pluijm W.V.D. Global prevalence of type 2 diabetes over the next ten years (2018–2028) // Diabetes. – 2018. – Vol. 67, suppl. 1. Kaiser A.B., Zhang N., Pluijm W.V.D. Global prevalence of type 2 diabetes over the next ten years (2018–2028) // Diabetes. – 2018. – Vol. 67, suppl. 1. Komajda M., Anker S.D., Charlesworth A. et al. for the COMET Investigators. The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET // Eur Heart J. – 2006; 27(12):1440-6. Komajda M., Anker S.D., Charlesworth A. et al. for the COMET Investigators. The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET // Eur Heart J. – 2006; 27(12):1440-6. Holland D.C., Lam M. Predictors of hospitalization and death among pre-dialysis patients: a retrospective cohort study. Nephrol Dial Transplant. – 2000 May; 15(5):650–8.30. Holland D.C., Lam M. Predictors of hospitalization and death among pre-dialysis patients: a retrospective cohort study. Nephrol Dial Transplant. – 2000 May; 15(5):650–8.30. Мохорт Т.В. Анемия и сахарный диабет: случайная или закономерная связь? // Медицинские новости. – 2001. – № 3. – С. 76–81. Mohort T.V. Anemiya i saharnyy diabet: sluchaynaya ili zakonomernaya svyaz'? // Medicinskie novosti. – 2001. – № 3. – S. 76–81. Smaradottir M.I., Ritsinger V., Gyberg V. et al. Copeptin in patients with acute myocardial infarction and newly detected glucose abnormalities – A marker of increased stress susceptibility? A report from the Glucose in Acute Myocardial Infarction cohort. Diab Vasc Dis Res. – 2017; 14 (2):69–76. Smaradottir M.I., Ritsinger V., Gyberg V. et al. Copeptin in patients with acute myocardial infarction and newly detected glucose abnormalities – A marker of increased stress susceptibility? A report from the Glucose in Acute Myocardial Infarction cohort. Diab Vasc Dis Res. – 2017; 14 (2):69–76.